Medyria has developed an innovative and unique prototype that significantly increases the effectiveness of tests to detect obstructive and non-obstructive coronary artery disease. Medyria Nombre Medyria Estrategia Early Stage Línea de Negocio Venture Capital Estado Current Portfolio Fundadores Mauro Sette Sede Winterthur, Switzerland Web https://www.medyria.com/